PALO ALTO, Calif., Sept. 4, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that presentations on its research will be made at EURETINA 2019 Congress being held from September 5 &ndas

AUSTIN, Texas, Sept. 4, 2019 /PRNewswire/ -- The Hogg Foundation for Mental Health is accepting proposals for the Texas Communities Count initiative, which will

BOSTON, Sept. 4, 2019 /PRNewswire/ -- Ethos today announced that the organization's Board of Directors has appointed Valerie Frias as Chief Executive Officer, succeeding Dale Mitchell, who is retiring after nearly 30 years of service. As CEO, Frias will be responsible for providing vision, leadership, and

LOS ANGELES, Sept. 4, 2019 /PRNewswire/ --If You Purchased PROVIGIL®, NUVIGIL®, or Generic Provigil® (Modafinil) a CALIFORNIA ATTORNEY GENERAL Settlement Could Affect YouINFORMATION ABOUT THE CALIFORNIA

NEWARK, Calif., Sept. 4, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on August 30, 2019, it issued inducement awards to two recently hired employees in accordance with their employment offer letters. The awards were granted under the Protagonist Therapeutics Inducement Award Plan, which was adop

PRINCETON, N.J. and SAN DIEGO, Sept. 4, 2019 /PRNewswire/ -- Adastra Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of proprietary medicines for the treatment of cancer, today announced that Scott Megaffin, Chief Executive Officer, will present at the 2019 Janney Healthcar

PORTSMOUTH, N.H., Sept. 4, 2019 /PRNewswire/ -- MediSpend, a leading provider of global compliance solutions for the life sciences industry, continues the evolution of its leadership team to support growing demand. The company announced today it has named Craig Hauben as chief executive officer to provide strategic guidance of the company's

PHILADELPHIA, Sept. 4, 2019 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) launched a new pilot program today aimed at improving the health and well-being of mothers and their young children. The project, "Community-Clinical Systems Integration: Leveraging Primary Care to Enhance Home Visiting and Other Early Childhood Su

INDIANAPOLIS, Sept. 4, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley Global Healthcare Conference on Wednesday, September 11, 2019. Daniel Skovronsky, M.D., Ph.D., Lilly's Chief Scientific Officer and President of Lilly Research Laboratories, will participate in a fi

TOLEDO, Ohio, Sept. 4, 2019 /PRNewswire/ -- Welltower Inc. (NYSE: WELL) today announced that Tim McHugh has been named Senior Vice President, Chief Financial Officer.  Mr. McHugh has been with the Company since 2016 and most recently served as Senior Vice President, Corporate Finance.